BioClinica Expands Operational Capabilities, Opens New European Offices
News Jul 02, 2015
BioClinica®, Inc. has announced the opening of new and expanded offices in London and Munich to better serve its growing client base in Europe. The facilities will offer an array of clinical trial services including medical imaging, site training and support, and eClinical product lines to meet the growing need of European drug and medical device sponsors.
BioClinica's clients include top pharmaceutical, biotechnology, and medical device companies as well as CRO partnerships in Europe and across the globe.
"Our new offices will serve as important hubs that enable efficient delivery of tailored resources to our European and Global clients" said John Hubbard, BioClinica's CEO. "Infrastructure investments and the recruitment of local scientific, medical, and regulatory expertise highlights BioClinica's firm commitment to supporting clinical drug development in Europe".
Together, the London and Munich offices offer a combined space of 1,400 square meters to support clinical trial services across key therapeutic areas. With a focus on medical imaging, the European offices will showcase an advanced image analysis center for BioClinica's extensive network of European radiologists and imaging specialists.
"Our expansion will provide the resources needed for regional scientific and medical experts to assemble and deliver high quality central review of imaging data for multisite trials in Europe" said David Herron, BioClinica's President of Medical Imaging, Cardiovascular Safety, and Molecular Markers.
BioClinica is holding an open house event for the London office on July 2nd for clients, sponsors, and partners in which members of the Executive Leadership team and representatives from BioClinica's Medical Imaging and Biomarker, Site network and patient recruitment, and eClinical business segments will be on hand to discuss and demonstrate clinical trial capabilities.
BioClinica is poised to expand its eClinical division in Europe, delivering products and showcasing technologies that facilitate efficient drug development in the region. "Our newly expanded offices provide an interactive environment for training and demonstration of our eClinical technology suite" said Mukhtar Ahmed, President of eClinical Solutions.
The London office is located at 72 Hammersmith Road and the Munich office is located at Landsberger Strasse 290. BioClinica has plans for an Open House at the Munich office later this summer.
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019